Clinical outcome study of crizotinib in IHC proven EML4-ALK fusion gene among Indian patients with adenocarcinoma lung

被引：0
|
作者：
Batra, U. [1 ]
Sharma, M. [2 ]
Jain, A. [1 ]
Agarwal, M. [1 ]
Goyal, P. [2 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Med Oncol, New Delhi, India
[2] Rajiv Gandhi Canc Inst, Med Oncol, Delhi, India
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
469P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Atypical Lung Carcinoids with EML4-ALK Fusion and Responses to ALK Inhibitors
    Waliany, Sarah
    Hung, Yin P.
    Abu Rous, Fawzi
    Do, Andrew
    Peterson, Jennifer
    Meservey, Caitlin
    Digumarthy, Subba R.
    Gadgeel, Shirish M.
    Lin, Jessica J.
    Meadori, Catherine B.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E32 - E33
  • [42] Long-Term Response to Gefitinib and Crizotinib in Lung Adenocarcinoma Harboring Both Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion Gene
    Chiari, Rita
    Duranti, Simona
    Ludovini, Vienna
    Bellezza, Guido
    Pireddu, Anjuta
    Minotti, Vincenzo
    Bennati, Chiara
    Crino, Lucio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : E30 - E32
  • [43] A Case of EML4-ALK Fusion Lung Adenocarcinoma in an 18-year-old Patient
    Chang, A.
    De, A.
    Kass, A. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] Primary lung adenocarcinoma with breast metastasis harboring the EML4-ALK fusion: A case report
    Zhang, Wenwen
    Zhang, Yu
    Zhou, Lei
    Tan, Na
    Bai, Yuju
    Xing, Shiyun
    ONCOLOGY LETTERS, 2024, 27 (06)
  • [45] EML4-ALK fusion gene expressing transgenic mouse for lung cancer model
    Pyo, Kyoung-Ho
    Kim, Hye Ryun
    Lim, Sun Min
    Yun, Mi Ran
    Kim, Sung-Moo
    Kim, Hwan
    Kang, Han Na
    Lee, Ji Min
    Kim, Sang Gyun
    Cho, Byoung Chul
    CANCER RESEARCH, 2016, 76
  • [46] EML4-ALK fusion gene in non-small cell lung cancer
    Lei, Yu
    Lei, Yan
    Shi, Xiang
    Wang, Jingjing
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [47] EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR
    Wu, Shang-Gin
    Kuo, Yao-Wen
    Chang, Yih-Leong
    Shih, Jin-Yuan
    Chen, Ya-Hui
    Tsai, Meng-Feng
    Yu, Chong-Jen
    Yang, Chih-Hsin
    Yang, Pan-Chyr
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 98 - 104
  • [48] Evidence that the Lung Adenocarcinoma EML4-ALK Fusion Gene Is not Caused by Exposure to Secondhand Tobacco Smoke During Childhood
    Ryan, Brid M.
    Wang, Yi
    Jen, Jin
    Yi, Eunhee S.
    Olivo-Marston, Susan
    Yang, Ping
    Harris, Curtis C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (07) : 1432 - 1434
  • [49] EML4-ALK rearrangement in blood platelets and outcome to crizotinib in non-small-cell lung cancer patients.
    Karachaliou, Niki
    Nilsson, R. Jonas A.
    Berenguer, Jordi
    Capitan, Ana Gimenez
    Schellen, Pepijn
    Teixido, Cristina
    Kuiper, Justine Leonie
    Drees, Esther
    Grabowska, Magda
    van Keulen, Marte
    Tannous, Jihane M.
    Heideman, Danielle
    Thunnissen, Erik
    Dingemans, Anne-Marie C.
    Ramirez, Santiago Viteri
    Tannous, Bakhos A.
    Drozdowskyj, Ana
    Smit, Egbert F.
    Wurdinger, Thomas
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Transformation of EML4-ALK fusion-positive adenocarcinoma into squamous cell carcinoma in association with acquired resistance to crizotinib
    Wang, Fenfang
    Qin, Jing
    Xie, Fajun
    Wu, Qihuan
    Lu, Hongyang
    LUNG CANCER, 2020, 140 : 118 - 120
12345